GP BC Partners, Canadian pension fund PSP Investments and other minority co-investors have sold their stakes in France-based Antelliq (formerly Allflex), a devices provider for animal identification and traceability, to US-based Merck in a deal valued at more than €3bn.
GP invests in the software company via Essling Expansion, a fund that recently held a first close
BVA expects to become one of the main market research groups in Europe and reach revenues of €200m
GP sold Ober Scharrer to Nordic last year, generating a 3.6x return on its original investment
NIBC and existing investors including Prime also took part in the round for the SME lender